Skip to content
The Longevity Archive

Legal status · United Kingdom

Is Navepegritide legal in the United Kingdom?

InvestigationalHormoneEvidence: Strong

No. Navepegritide is not approved for any medical use in the United Kingdom; its classification is "Not yet licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Strong.

Navepegritide in the United Kingdom at a glance

ClassificationNot yet licensed
MHRA approval statusNot approved by MHRA; investigational
Evidence levelStrong (research strength: Strong)
ReviewedSep 2026

Classification and note come from the Navepegritide profile, checked against Medicines and Healthcare products Regulatory Agency (MHRA) listings at the reviewed date.

What this means

  • 01

    Navepegritide is being studied in registered clinical trials but has not received MHRA marketing approval in the United Kingdom.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Navepegritide is

A once-weekly prodrug of C-type natriuretic peptide, FDA-approved in February 2026 for achondroplasia in children aged two and older.

Navepegritide releases C-type natriuretic peptide slowly from a carrier, giving a weekly injection that counters the overactive FGFR3 signaling of achondroplasia. 41 on placebo.

Mechanism: Sustained-release CNP analog that stimulates natriuretic peptide receptor B, inhibiting the MAPK pathway downstream of FGFR3 in growth-plate cartilage.

Regulatory history: FDA-approved (accelerated) for achondroplasia, 2026

How MHRA treats this kind of product

Licenses medicines for the UK market. A compound without a marketing authorisation is an unlicensed medicine, which can only lawfully be supplied for human use through a prescriber under the specials scheme, not sold as a research product.

The classification above is the The Longevity Archive reading of Medicines and Healthcare products Regulatory Agency listings for Navepegritide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Navepegritide in other countries

Frequently asked questions

Is Navepegritide legal in the United Kingdom?

No. Navepegritide is not approved for any medical use in the United Kingdom; its classification is "Not yet licensed". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Strong.

Can I buy Navepegritide in the United Kingdom?

No approved product exists to buy. In the United Kingdom Navepegritide is classified as "Not yet licensed", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Navepegritide MHRA approved?

No. In the United Kingdom Navepegritide is classified as "Not yet licensed", which is not a MHRA marketing approval. For comparison, the US FDA status is: FDA-approved (accelerated) for achondroplasia, 2026. Evidence level: Strong.

Related compounds in the United Kingdom

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Navepegritide live on its compound profile.

Navepegritide profile

This page is general information about the regulatory status of Navepegritide in the United Kingdom, current as of Sep 2026. It is not legal advice, and classifications change; check Medicines and Healthcare products Regulatory Agency directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.